MIYARISAN SEIBUTSU IGAKU KENKY has a total of 12 patent applications. Its first patent ever was published in 1990. It filed its patents most often in Japan, EPO (European Patent Office) and Hungary. Its main competitors in its focus markets pharmaceuticals, machines and mechanical elements are STEIGERWALD ARZNEIMITTELWERK GMBH, COLUMBIA LAB BERMUDA LTD and NAGAI KINESHIRO.
# | Country | Total Patents | |
---|---|---|---|
#1 | Japan | 6 | |
#2 | EPO (European Patent Office) | 2 | |
#3 | Hungary | 2 | |
#4 | Republic of Korea | 1 | |
#5 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Machines | |
#3 | Mechanical elements |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Unspecified technologies | |
#4 | Gearing |
# | Name | Total Patents |
---|---|---|
#1 | Taguchi Nobuhiro | 7 |
#2 | Fujita Itsuki | 5 |
#3 | Maeda Akio | 4 |
#4 | Kusunoki Masataka | 4 |
#5 | Kuroiwa Toyoaki | 4 |
#6 | Otoari Kiyotaka | 2 |
#7 | Takashi Katsuo | 2 |
#8 | Yazawa Katsukiyo | 1 |
#9 | Ishibashi Masami | 1 |
#10 | Kobayashi Junichi | 1 |
Publication | Filing date | Title |
---|---|---|
JPH10316519A | Controlling agent against plant disease injury | |
JPH0723775A | Microorganism exhibiting antibacterial action on gram-positive bacteria including methicillin-resistant staphylococcus aureus (mrsa) | |
JPH0641180A | New anthracyclin compound and its production | |
US5266315A | Composite for Clostridium difficile diarrhea and pseudomembranous colitis | |
JPH06166625A | Liquid agent of clostridium butyricum | |
JPH07145A | Composition of butyric acid bacterium | |
HU911188D0 | Preventive and curative pharmaceutical composition for curing diarrhoea and pseudomembranous colitis caused by clostridium difficile | |
JPH0656679A | Prophylactic and therapeutic composition for clostridium difficile diarrhea and pseudomembranous colitis |